View Older Stories View More Recent Stories
-
Roth Capital Sees More Upside For SolarEdge Technologies (SEDG) PT To Street High $60
-
Genetic Technologies (GTG) Reports Strategic Alliance and Capital Raising
-
Avid Bioservices (CDMO) Prices 9M Share Common Offering at $2.25/Sh
-
Avid Bioservices Announces Pricing of Public Offering of Common Stock
-
Genetic Technologies Announces Strategic Alliance and Capital Raising
-
Inpixon (INPX) Announces Public Offering
-
Inpixon Launches Public Offering
-
Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results
-
CHALLENGED ATHLETES FOUNDATION ANNOUNCES INAUGURAL NORTHERN CALIFORNIA FUNDRAISING EVENT ‘A CELEBRATION OF HEART’
-
CHALLENGED ATHLETES FOUNDATION ANNOUNCES INAUGURAL NORTHERN CALIFORNIA FUNDRAISING EVENT ‘A CELEBRATION OF HEART’
-
GoldMining Issues Letter to Shareholders and Reports on Company Plans for 2018
-
U.S. Gold Corp (USAU): Keystone Comes Up Short, PT To $2.75 - Roth
-
Himax Technologies (HIMX) PT Lowered to $12 at Roth Capital on 4Q; 'Near-Term Headwinds Ahead of 3D Sensing Ramp'
-
Dare Bioscience (DARE) Prices Offering of Common Stock, Warrants
-
Daré Bioscience, Inc. to raise approximately $10.25 million
-
Daré Bioscience, Inc. to raise approximately $10.25 million
-
Dare Bioscience (DARE) Plans to Offer Common Stock and Warrants (Yesterday)
-
Insperity (NSP): Strong Close to 2017, PT To $71 - Roth
-
Shopify (SHOP) PT Raised to $144 at Roth Capital; 'Checks Suggest Strong 4Q/Guide'
-
Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
-
Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
-
Motorcar Parts of Americabb (MPAA) PT Lowered to $26 at Roth Capital
-
Avid Bioservices (CDMO), Oncologie Enter Asset Assignment and Purchase Agreement for Avid's PS-Targeting Program Including Bavituximab
-
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab
-
Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients
-
One Stop Systems, Inc. Announces Partial Exercise of Over-Allotment Option for Initial Public Offering
-
One Stop Systems, Inc. Announces Partial Exercise of Over-Allotment Option for Initial Public Offering
-
UPDATE: Roth Capital Upgrades FuelCell Energy (FCEl) to Buy
-
Melco Resorts & Entertainment Limited (MLCO) PT Raised to $38 at Roth Capital
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $210 at Roth Capital Following MGL-3196 Achieving Primary Endpoint
-
Roth Capital Starts Transcat Inc. (TRNS) at Buy
-
Gemphire Therapeutics (GEMP) Prices 3.14M Common Stock Offering at $7/Share
-
Gemphire Announces Pricing of $22 Million Public Offering of Common Stock
-
Lannett Co (LCI) PT Lowered to $25 at Roth Capital
-
Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy, 'High Ambitions, High Reward'
-
Roth Capital Upgrades Manitex International (MNTX) to Buy
-
Digital Turbine (APPS) PT Raised to $3.25 at Roth Capital, 'Healthy Ad Growth Should Carry Momentum into FY19'
-
Knowles Corp (KN) PT Lowered to $18 at Roth Capital, 'Adjusting for Muted Smartphone Demand'
-
Evolution Petroleum Increases Common Stock Dividend by 33% to $0.10 per Share; Announces Results for Fiscal 2018 Second Quarter Ended December 31, 2017
-
Roth Capital Said Wynn Resorts (WYNN) Sale is 'Unlikely'
-
Colliers International Partners with Flexible Office Leader LiquidSpace to Better Serve Clients through Technology
-
Dynamic Materials (BOOM) PT Raised to $27 at Roth Capital
-
Roth Capital Downgrades Wynn Resorts (WYNN) to Neutral, 'Removing a Visionary, not an Overhang'
-
Remark Media (MARK) Refutes 'Misleading', 'Inaccurate' Report and False Allegations
-
Remark Holdings Refutes Misleading and Inaccurate Report and False Allegations About the Company
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
8point3 Energy Partners LP (CAFD) PT Lowered to $12.35 at Roth Capital Following Announced Sale
-
One Stop Systems, Inc. Announces Closing of Initial Public Offering
-
One Stop Systems, Inc. Announces Closing of Initial Public Offering
-
Klondex Mines (KLDX) PT Lowered to $3.50 at Roth Capital

